Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ryder, Justin
NCT03867487: SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease	Not yet recruiting	2	40	US	Empagliflozin 10 MG, Jardiance, Placebo Oral Tablet, Control group	Ann & Robert H Lurie Children's Hospital of Chicago	Non-Alcoholic Fatty Liver Disease, NAFLD, Pediatric NAFLD	12/29	12/29
PASIPHY, NCT05928390: Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia	Recruiting	2	72	Europe, US	Pasireotide Diaspartate, Pasireotide	RECORDATI GROUP	Post-Bariatric Hypoglycemia	04/25	04/26
ADMIRE, NCT05125822: Adaptive Mechanisms Responsible for Weight Change in Youth With Obesity	Recruiting	N/A	260	US	Meal replacement and lifestyle modification	Ann & Robert H Lurie Children's Hospital of Chicago	Childhood Obesity	05/26	01/28
NCT04100109: Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic	Not yet recruiting	N/A	40	NA	Polylactose, Placebo	University of Minnesota	Obesity, Adolescent, Obesity, Childhood	10/27	10/27
George, Rafeedie
PASIPHY, NCT05928390: Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia	Recruiting	2	72	Europe, US	Pasireotide Diaspartate, Pasireotide	RECORDATI GROUP	Post-Bariatric Hypoglycemia	04/25	04/26